Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Blockchain Press Releases

ILIKOS Consulting Group and Simmunome Announce Strategic Partnership aimed at:

Published

on

ilikos-consulting-group-and-simmunome-announce-strategic-partnership-aimed-at:
  1. Offering advanced development insight to biopharmaceutical companies as a means of enabling better outcomes.
  2. Mitigating risk across all phases of the development pathway by performing experiments in silico to simulate biological processes allowing clinical researchers to focus on the right targets and right patient populations, resulting in streamlined advancement of effective therapies.

LIMASSOL, Cyprus, Aug. 1, 2023 /PRNewswire/ — With the average new drug taking 10 years in clinical development, combined with a $2B+ price tag and 90% failure rate, the clinical research model is no longer sustainable in today’s market conditions. Furthermore, many drug failures happen at the late-stage of development, creating devastating losses and disappointment for patients and their families.

The significant growth of AI applications in drug development coupled with the decreasing cost of computing power required to analyze large datasets, enables more informed decisions and better investment strategies. Biological complexity remains the number one challenge in clinical research but with millions of past experiments and clinical trials performed by the collective scientific community and many results residing in the public domain, it’s time to put it all together to create a holistic model of each disease.

“Working closely with emerging biopharmaceutical companies has been a foundational objective since our inception. Adding Simmunome into our ecosystem of strategic partners enables us to extend their cutting-edge AI technology to our clients, helping them de-risk their development programs, make better informed decisions and gain more control over outcomes” – said Mr. Elias Sayias BSc. CCRA, Founder and CEO of ILIKOS.

Simmunome Untangles Biological Complexity Using AI

With a robust disease-agnostic platform and an expertise in molecular biology, bioinformatics, machine learning, and computational biology, Simmunome is uniquely positioned to tackle the most complex biological questions related to disease mechanisms and how the molecular pathways are linked to clinical outcomes. The benefits of simulating clinical outcomes come in the form of better anomaly detection, future event forecasting and better clinical development decisions.

“Simmunome’s platform can be leveraged by our clients in both academic and private sectors across all stages of development, starting from the early drug discovery process, enhancing operational efficiencies. This approach can solve key challenges while enabling faster and more efficient discovery and development of new drugs. We are very excited about the potential of this partnership.” – said Dr. Styliana Mirallai, Corporate Development Manager.

“The crucial role of ILIKOS in providing comprehensive consulting services to biopharmaceutical and medical technology companies is imperative considering the increasing costs of clinical research and development while navigating an evolving regulatory landscape. This strategic partnership with ILIKOS presents an exciting opportunity for Simmunome, as we combine our expertise and resources to confidently make groundbreaking advancements in the field. We look forward to leveraging our platform capabilities and working closely with our partners to drive innovation and ultimately improve clinical development efficacies and more importantly, patient outcomes.” said Dr Murira, CEO of Simmunome.

“We are ecstatic to partner with ILIKOS because of the personalized approach they take with their clients. ILIKOS sees the value and tremendous power of AI in clinical development and is well-positioned to allow Simmunome to serve biopharmaceutical companies in North America, Europe and the META regions,” said Tanya Tolomeo, Head of Business Development of Simmunome.

About ILIKOS Consulting Group

ILIKOS offers flexible, adaptive and highly personalized consulting services to biopharmaceutical and medical technology companies helping them progress the development of their investigational products. ILIKOS also works closely with a wide range of Contract Research Organizations (CROs) to establish and execute highly effective business & corporate development strategies.

To learn more, please visit: www.goilikos.com  

For further information, please contact:
Dr. Styliana Mirallai
Corporate Development Manager
e-mail: [email protected]

About Simmunome

Simmunome is at the leading edge of leveraging AI towards unraveling biological complexity. Simmunome’s platform allows users to input preclinical and clinical data to derive disease-specific insights and help R&D researchers make critical go/no-go decisions. By combining multi-omic data to create comprehensive models of disease, Simmunome simulates biological processes to identify novel drug targets and predict and improve clinical outcomes. Simmunome de-risks clinical research, reduces R&D costs and dramatically accelerates health research and innovation.

To learn more, please visit: www.simmunome.com 

For further information, please contact:
Tanya Tolomeo
Head of Business Development
e-mail: [email protected] 

View original content:https://www.prnewswire.co.uk/news-releases/ilikos-consulting-group-and-simmunome-announce-strategic-partnership-aimed-at-301886509.html

Continue Reading

Blockchain Press Releases

KuCoin Campus Survey Reveals: 88% of Participants Eager to Build Careers in Blockchain

Published

on

kucoin-campus-survey-reveals:-88%-of-participants-eager-to-build-careers-in-blockchain

VICTORIA, Seychelles, April 30, 2024 /PRNewswire/ — KuCoin, a leading global crypto exchange, has launched a survey report on Blockchain Education and Career as its new KuCoin Campus initiative, aiming to understand global interest in blockchain education and careers. This effort marks the beginning of their educational campaign, focusing on engaging in offline interaction to enhance learning.

The survey has unveiled a high interest in learning and pursuing a career in the blockchain industry, with responses from over 1900 survey participants, reflecting a promising talent pool that industry partnerships and career guidance can harness, and a substantial market for job opportunities and professional development in this field.

In the heart of KuCoin’s survey, an overwhelming 88% of respondents showcase their eagerness to embark on blockchain careers. This enthusiasm is further evidenced by the 75% of participants who declare a “very high” interest in the blockchain sphere, indicating a widespread recognition of its transformative capabilities.

The survey also delves into the experience levels of blockchain enthusiasts, revealing that 65% of respondents have been engaged with the industry for at least a year, including a notable 15% with over three years of experience. This diverse mix of newcomers and veterans highlights the industry’s dynamic nature and the continuous influx of fresh talent.

Engagement preferences further reflect the community’s diverse approach to blockchain, with 49% favoring investment as a means of learning, followed by the use of blockchain services and applications (39%), and formal education and community involvement trailing closely. This indicates a broad spectrum of entry points into the blockchain world, from financial investment to academic pursuit and community participation.

Moreover, the survey sheds light on the core principles that intrigue participants, with 51% fascinated by blockchain’s potential in reshaping finance and its prospects for high profitability. Regarding practical applications, investing and trading (51%) and the pursuit of passive income (49%) stand out as areas of keen interest, alongside the exploration of AI integration, digital assets, and cross-border payment solutions. This indicates a strong interest in leveraging blockchain for financial gain and innovation.

The survey offers crucial insights for a diverse audience, including investors, organizations, and individuals either working in or aspiring to join the blockchain industry. This initiative represents a strategic step towards aligning KuCoin’s educational efforts with the evolving needs and interests within the blockchain realm. Please read the full report here.

About KuCoin Campus

KuCoin Campus is a global initiative set to unfold through a series of dynamic offline events at schools and colleges around the world. While KuCoin Learn serves as our comprehensive online learning platform, KuCoin Campus extends its educational endeavor into the physical realm. It aims to engage with academic communities, enlightening students and educators alike about the burgeoning world of digital finance and its potential impact on the future.

Logo – https://mma.prnewswire.com/media/2356857/KuCoin_Horizontal_Green_LOGO_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/kucoin-campus-survey-reveals-88-of-participants-eager-to-build-careers-in-blockchain-302131283.html

Continue Reading

Blockchain Press Releases

Bosera HashKey Bitcoin and Ether Spot ETFs Officially Launch on HKEX with Two-Way Investment Flexibility

Published

on

bosera-hashkey-bitcoin-and-ether-spot-etfs-officially-launch-on-hkex-with-two-way-investment-flexibility

HONG KONG, April 30, 2024  /PRNewswire/ — The Exchange Traded Funds, Bosera HashKey Bitcoin ETF and Bosera HashKey Ether ETF (the “ETFs”) have officially launched on the Hong Kong Stock Exchange today. In respect of the ETFs, Bosera Asset Management (International) Co., Limited and HashKey Capital Limited are the Investment Manager and Sub-Investment Manager respectively. The ETFs are part of the first batch of Bitcoin and Ether spot ETFs to launch in a major financial hub in Asia and they are now listed under the tickers  BTC: 3008.HK (HKD); 9008.HK (USD) and ETH: 3009.HK (HKD); 9009.HK (USD) respectively.

One of the key features of these ETFs is that they introduce an ‘in-kind’ subscription mechanism, which allows investors to directly subscribe for ETF shares using Bitcoin and Ethereum. Investors can purchase the ETFs with Bitcoin or Ethereum and subsequently sell them for cash, or vice versa, enabling seamless two-way investment flexibility.

Additionally, the Bosera HashKey Bitcoin ETF and Bosera HashKey Ether ETF track the CME CF Bitcoin Reference Rate – Asia Pacific Variant and the CME CF Ether-Dollar Reference Rate – Asia Pacific Variant respectively.

“The launch of the Bosera HashKey Bitcoin ETF and Bosera HashKey Ether ETF marks a significant leap forward in democratizing access to cryptocurrencies,” said Deng Chao, CEO of HashKey Capital. “These innovative ETFs not only provide a convenient entry point for investors but also underscore our commitment to driving innovation in the virtual asset ecosystem.”

Importantly, non-Hong Kong nationals can also subscribe for or purchase units in the ETFs if they meet local regulatory requirements, such as passing customer due diligence.

The Bosera HashKey Bitcoin ETF and Bosera HashKey Ether ETF are now available for trading on the Hong Kong Stock Exchange.

Note: The tickers BTC: 3008.HK (HKD); 9008.HK (USD) and ETH: 3009.HK (HKD); 9009.HK (USD)are now officially listed on the Hong Kong Stock Exchange (HKEX).

About HashKey Capital

Global in influence and crypto-native, HashKey Capital is a digital asset and blockchain leader helping institutions, founders and talents advance the blockchain industries.

As one of the largest crypto funds and the earliest institutional investor in Ethereum, HashKey Capital has managed over US$1 billion in client assets since its inception, with over 500 investments in infrastructure, tools, and applications.

With our deep knowledge across the blockchain ecosystem, HashKey Capital has built a robust network connecting founders, investors, developers, and regulators.

For media enquiries, please contact [email protected] ; [email protected] 

Logo – https://mma.prnewswire.com/media/2400243/CAPITAL_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/bosera-hashkey-bitcoin-and-ether-spot-etfs-officially-launch-on-hkex-with-two-way-investment-flexibility-302130349.html

Continue Reading

Blockchain

No plans for total crypto ban in Russia, lawmaker says

Published

on

no-plans-for-total-crypto-ban-in-russia,-lawmaker-says

A lawmaker in Russia has stated that there are no plans for a total ban on cryptocurrencies in the country. This statement provides clarity on the regulatory stance of the Russian government regarding cryptocurrencies and addresses concerns about potential prohibitive measures.

The clarification from the lawmaker indicates that while Russia may be considering regulations to govern the use and trading of cryptocurrencies, there are no intentions to outright ban their existence or usage. This stance suggests a more nuanced approach to cryptocurrency regulation, aiming to balance innovation and development in the digital asset space with regulatory oversight and consumer protection.

The statement may help alleviate uncertainty and fears within the cryptocurrency community in Russia, as well as among international investors and stakeholders. Clear regulatory guidelines and a willingness to engage with the crypto industry can foster a more conducive environment for innovation, investment, and economic growth.

The lawmaker’s assertion that there are no plans for a total crypto ban in Russia provides reassurance to market participants and signals a potentially more constructive approach to cryptocurrency regulation in the country. It remains to be seen how regulatory frameworks will evolve in Russia, but this statement suggests a willingness to engage in dialogue and develop regulations that support the growth of the crypto industry while addressing regulatory concerns.

Source: crypto.news

The post No plans for total crypto ban in Russia, lawmaker says appeared first on HIPTHER Alerts.

Continue Reading
Advertisement
Advertisement

Latest News

Recent Listings

  • Global Payout, Inc.

    Since the Company’s inception in 2009, Global Payout, Inc. has been a leading provider of compreh...

  • MTrac Tech Corp.

    MTrac Tech Corporation, a Nevada Corporation, is a privately held, wholly owned subsidiary of Glo...

  • Net1

    Net1 is a leading provider of transaction processing services, financial inclusion products ...

  • uBUCK Technologies SEZC

    Based in Georgetown, Cayman Islands, uBUCK Tech is a fintech enterprise that specializes in digit...

  • LiteLink Technologies Inc.

      LiteLink is a major player in developing world-class enterprise platforms that utilize ar...

  • Good Gamer Corp.

      Good Gamer Corp. is a privately-held technology company focusing on gamers and streamers....

  • BitPay

      Founded in 2011, BitPay pioneered blockchain payment processing with the mission of trans...

  • About Net1

      Net1 is a leading provider of transaction processing services, financial inclusion produc...

  • Blockchain Foundry Inc.

    Headquartered in Toronto, Canada, Blockchain Foundry (CSE:BCFN)(FWB:8BF)(OTC:BLFDF) is a global b...

  • Sixgill

    Sixgill provides a full suite of universal data automation and authenticity products and services...

Trending on TBE